11-01-19 - News

HYLOMORPH AG was awarded the Innosuisse Certificate

After a three years process Innosuisse certifies HYLOMORPH AG as “ready for sustainable growth”. The program for start-up coaching is divided into three parts in which experience business coaches advise and support companies and lead them to ensure their sustainable growth. Simone Bottan, CEO, said "Innosuisse has been fundamental in guiding HYLOMORPH out of academia into a commercial venture”.

read more

05-01-19 - Media Coverage

SRF Tagesschau – „Spin-off-Boom an der ETH Zürich”

Wyss Zurich project Sevensense is one of the 27 companies, which were founded last year at the ETH Zurich. Sevensense benefits from the financial support of Wyss Zurich, the access to a world-class infrastructure as well as the support in analysis and business strategy. The team of 12 develops solutions that enable robots to measure their position with a high level of accuracy and to navigate precisely and safely in dynamic environments. Similar to the human eye and inner ear, these systems process images from cameras and an inertial measurement unit to construct a map of the surroundings and pinpoint their position on the map.

read more

30-12-18 - Media Coverage

SRF Aeschbacher – „Das Tier der Zukunft: ANYmal”

Péter Fankhauser and Linus Isler from the Wyss Zurich project ANYmotion were presenting ANYmal at the very last SRF Aeschbacher show. ANYmotion provides solutions for robot applications with the most advanced mobility and autonomy requirements in challenging terrain. The four-legged mobile robot system moves and operates autonomously and interacts safely with the environment. ANYmal is able to climb, crawl, walk, run, carry, jump or even to dance. The TV contribution about ANYmal starts at minute 45.00 (in German).

read more

05-12-18 - Media Coverage

swissinfo.ch – „Sizilianerin züchtet in Zürich personalisiertes Hauttransplantat”

Around 50 million people around the world suffer from severe skin problems. The scientist Dr. Daniela Marino, Co-Project Leader of the Wyss Zurich project denovoSkin, has developed with her start-up CUTISS AG a revolutionary method to produce human skin in the laboratory. The personalized skin graft is based on the cells of each patient. This new healing method called denovoSkin is a hope for millions of people, whose skin has been damaged by burns, illness, surgery or other causes. The first clinical trials of denovoSkin have led to hopeful results. The skin graft is derived from the cells of each patient, so there are no intolerances or other secondary consequences. Read the full article on swissinfo.ch (in German).

read more

22-11-18 - Event

Clinical Colloquium Regenerative Medicine – December 3, 2018

Prof. Dr. Karin Wuertz-Kozak (Laboratory for Immunoengineering & Regenerative Medicine, Institute for Biomechanics, D-HEST, ETH Zurich) will talk about "Engineering therapeutic approaches to modulating inflammation" on Monday, December 3, 2018 from 1.00 - 2.00 p.m. at Institute for Regenerative Medicine (IREM), University of Zurich, Wagistrasse 12, WAD-904 (Founders Lab), 8952 Schlieren.

read more

22-11-18 - News

Seervision wins Swiss Technology Award

As part of the 13th Swiss Innovation Forum, a top-class jury selected the winners of the 2018 Swiss Technology Award in the three categories "Inventors", "Startups" and "Innovation Leaders". Seervision, one of our Wyss Zurich projects, won in the category "Inventors". Seervision develops state-of-the-art video analysis algorithms for real-time object recognition and scene segmentation in video productions.

read more

07-11-18 - Event

Al Gore visits Wyss Zurich

This year’s Wyss Zurich Annual Event, held on November 6, 2018, was quickly booked to capacity after the word spread that former U.S. Vice President and climate advocate Al Gore had agreed to be its keynote speaker. At that event, he joined some 300 invited guests from the academic, policy and business sectors in learning about the work of the startup accelerator Wyss Zurich, which is jointly operated by ETH Zurich and the University of Zurich, and its ongoing projects.

read full article

05-11-18 - Event

Seminar Translational and Clinical Wyss Zurich Projects

Dr. Daniela Marino and Dr. Fabienne Hartmann-Fritsch (Wyss Zurich – ETH Zurich / University of Zurich) will talk about "Personalized skin grafts to treat skin defects – Status quo within the Wyss Zurich denovoSkin project" on Tuesday, November 27, 2018 from 12.30 - 13.30 p.m. at University Hospital Zurich, Kleiner Hörsaal OST.

read more

03-11-18 - Spotlight

Schweiz am Wochenende – „Milliardär Hansjörg Wyss spendet Geld gegen Selbstbestimmungs-Initiative”

The Swiss entrepreneur and philanthropist Dr. h.c. mult. Hansjörg Wyss talks in an interview with "Schweiz am Wochenende" about his worldwide engagement, Swiss politics and why he does not travel to the WEF. He also made headlines worldwide this week: Berne billionaire Hansjörg Wyss wrote in The New York Times that we need to save the planet - and therefore he's donating $ 1 billion to protect the planet. What drives a person who spends billions for good causes? Read the interview in "Schweiz am Wochenende" (in german).

read more

31-10-18 - Media Coverage

Neue Zürcher Zeitung – „Nicht alles verdoppelt sich in 18 Monaten – wahrer Fortschritt braucht Zeit”

Although computing power and data are rising exponentially, this doesn’t mean that digitization will solve the world’s problems in an instant, says Wyss Zurich Founding Co-Director Roland Siegwart. The Moore’s Law shows how processing power per microchip has doubled roughly every 18 months since 1971. This phenomenon has been the driving force behind digitization; today’s cell phones have more computing power than NASA used to fly astronauts to the moon in the 1960s. Read the full article in NZZ (in German).

read more